Skip to main content
Journal ArticleOPEN ACCESS

The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients

Clinical Case Reports (2020) 8(9) 1722-1727
DOI: 10.1002/ccr3.2967
2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We demonstrate evidence supporting the efficacy of hydroxocobalamin in reducing vasopressor requirements for LVAD patients with refractory vasoplegia. Further study is needed to substantiate these findings and determine its optimal use in practice.

Author supplied keywords

Cite

CITATION STYLE

APA

Ayers, B., Wood, K., Falvey, J., Bernstein, W., & Gosev, I. (2020). The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients. Clinical Case Reports, 8(9), 1722–1727. https://doi.org/10.1002/ccr3.2967

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free